Clinical Trials on Metastatic Castration-resistant Prostate Cancer in Canada
Total 965 results
-
British Columbia Cancer AgencyRecruitingProstate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate CancerCanada
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
British Columbia Cancer AgencyCompletedMetastatic Castration-Resistant Prostate CancerCanada
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Université de SherbrookeCanadian Cancer Society (CCS); Fonds de la Recherche en Santé du Québec; Merck... and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerCanada
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerCanada
-
Rabin Medical CenterUniversity of TorontoCompletedDeath | Metastasis | Castration-resistant Prostate CancerCanada
-
British Columbia Cancer AgencyRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Canada
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
BayerRecruitingAdvanced Metastatic Castration-resistant Prostate Cancer | Prostate Specific Membrane Antigen (PSMA) ExpressionCanada, United Kingdom, Belgium
-
POINT Biopharma, a wholly owned subsidiary of Eli...Eli Lilly and CompanyRecruitingProstate Cancer | Biochemically Recurrent Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerCanada
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer Patients With OligometastasesCanada
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
Ottawa Hospital Research InstituteRecruitingBreast Cancer | Castration-resistant Prostate CancerCanada
-
British Columbia Cancer AgencyAchieve Life SciencesCompletedCastration Resistant Prostate CancerCanada, United States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
Sunnybrook Health Sciences CentreRecruitingOligoprogressive | Castration-Resistant Prostate CancerCanada
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina...UnknownAdvanced Prostate Cancer | Castration Resistant | EnzalutamideSpain
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina...UnknownAdvanced Prostate Cancer | Castration Resistant | Radium 223Spain
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada
-
Aragon Pharmaceuticals, Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom, Moldova, Republic of
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
zr Pharma & GmbHFoundation MedicineCompletedMetastatic Castration Resistant Prostate CancerUnited States, Spain, United Kingdom, France, Australia, Belgium, Denmark, Israel, Germany, Ireland, Canada, Italy
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
BayerCompletedMetastatic Castration-sensitive Prostate CancerCanada
-
Corvus Pharmaceuticals, Inc.Genentech, Inc.CompletedRenal Cell Cancer | Metastatic Castration Resistant Prostate CancerUnited States, Canada, Australia
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
University Health Network, TorontoCompletedMetastatic Prostate Cancer | Bone MetastasisCanada
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Sir Mortimer B. Davis - Jewish General HospitalTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Metastatic Prostatic Adenocarcinoma | Metastatic Prostate Carcinoma in the Soft TissueCanada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
Costantine AlbanyHoosier Cancer Research Network; Achieve Life SciencesTerminatedProstate Cancer | PSA | Metastatic Castrate-Resistant Prostate CancerUnited States, Canada
-
AB ScienceCompletedMetastatic Castrate Resistant Prostate CancerItaly, Russian Federation, India, Canada, France, Malaysia
-
Janssen Research & Development, LLCActive, not recruitingCastration-Resistant Prostatic CancerUnited States, China, Italy, Korea, Republic of, Taiwan, Australia, Sweden, Belgium, Canada, France, Hungary, Israel, Malaysia, Russian Federation, Portugal, Germany, Bulgaria, Spain, Netherlands, Turkey, United Kingdom, Ukraine, Po... and more
-
British Columbia Cancer AgencyCompletedProstate Cancer | Prostate Cancer Metastatic | Prostatic NeoplasmCanada
-
University Health Network, TorontoProstate Cancer CanadaCompletedMetastatic Prostate CancerCanada